caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1790770717

Matthew LippasM.D.

OphthalmologyDallas, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
906
Unique beneficiaries
—
Total services
9,568
Distinct HCPCS
12
Medicare payment
$420K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,238 Ophthalmology providers in TX — top quintile (cohort median 1,864).
REFERRAL NETWORK

Where Matthew Lippas's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
5197
John Haarde
Optometry · Dallas, TX
4686
Ralphana Ehrhardt
Ophthalmology · Dallas, TX
2857
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
2872
WOOD, THOMAS2850
BOLTON, CRAIG2746
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS2465
BAYLOR UNIVERSITY MEDICAL CENTER2132
Swdic Imaging Center Partnership, Llp
Independent Diagnostic Testing Facility (IDTF) · Dallas, TX
1847
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS1525
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
457
Beneficiaries
—
Total drug cost
$25K
Distinct drugs
12
Brand share
20.1%
Top prescribed drugs
Latanoprost130 claims
Ofloxacin70 claims
Timolol Maleate48 claims
Ciprofloxacin Hcl43 claims
Dorzolamide Hcl/Timolol Maleat27 claims
QUALITY · MIPS · 2024
Final MIPS score
92.7
Quality
100.0
Cost
75.6
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.74%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$50
Payment records
2
By payment type
Food and Beverage$50